Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study
(Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 18, 2024 Category: Cardiology Authors: Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk D éruaz-Luyet, Julie M. Paik and Elisabetta Patorno Tags: Correction Source Type: research
Effectiveness and safety of the combination of sodium –glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies
Randomized controlled trials and real-world studies suggest that combination therapy with sodium –glucose transport protein 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) is ass... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 18, 2024 Category: Cardiology Authors: Aftab Ahmad and Hani Sabbour Tags: Research Source Type: research
Triglyceride-glucose index: a novel evaluation tool for all-cause mortality in critically ill hemorrhagic stroke patients-a retrospective analysis of the MIMIC-IV database
Hemorrhagic stroke (HS), including non-traumatic intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH), constitutes a substantial proportion of cerebrovascular incidents, accounting for around 30% o... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 18, 2024 Category: Cardiology Authors: Yongwei Huang, Zongping Li and Xiaoshuang Yin Tags: Research Source Type: research
Hepatic insulin resistance and muscle insulin resistance are characterized by distinct postprandial plasma metabolite profiles: a cross-sectional study
Tissue-specific insulin resistance (IR) predominantly in muscle (muscle IR) or liver (liver IR) has previously been linked to distinct fasting metabolite profiles, but postprandial metabolite profiles have not... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 16, 2024 Category: Cardiology Authors: Anouk Gijbels, Bal ázs Erdős, Inez Trouwborst, Kelly M. Jardon, Michiel E. Adriaens, Gijs H. Goossens, Ellen E. Blaak, Edith J. M. Feskens and Lydia A. Afman Tags: Research Source Type: research
Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial
This study aimed to investigate whether shorter telomeres are associated with a ... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 16, 2024 Category: Cardiology Authors: Ana Ojeda-Rodriguez, Oriol A. Rangel-Zu ñiga, Antonio P. Arenas-de Larriva, Francisco M. Gutierrez-Mariscal, Jose D. Torres-Peña, Juan L. Romero-Cabrera, Alicia Podadera-Herreros, Helena García-Fernandez, Esther Porras-Pérez, Raul M. Luque, Stefanos N Tags: Research Source Type: research
Association between triglyceride-glucose index and intracranial/extracranial atherosclerotic stenosis: findings from a retrospective study
This study aimed to investigate the relati... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 14, 2024 Category: Cardiology Authors: Yu Xie, Kuan Cen, Bitang Dan, Li Zou, Lei Zhang, Renwei Zhang, Huagang Li, Qi Cai, Nadire Aiziretiaili, Zhenxing Liu and Yumin Liu Tags: Research Source Type: research
MCT4-dependent lactate transport: a novel mechanism for cardiac energy metabolism injury and inflammation in type 2 diabetes mellitus
Diabetic cardiomyopathy (DCM) is a major contributor to mortality in diabetic patients, characterized by a multifaceted pathogenesis and limited therapeutic options. While lactate, a byproduct of glycolysis, i... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 14, 2024 Category: Cardiology Authors: Xiu Mei Ma, Kang Geng, Peng Wang, Zongzhe Jiang, Betty Yuen-Kwan Law and Yong Xu Tags: Research Source Type: research
Sex differences in the relationship between serum total bilirubin and risk of incident metabolic syndrome in community-dwelling adults: Propensity score analysis using longitudinal cohort data over 16 years
Research on identifiable risks for metabolic syndrome (MetS) is ongoing, and growing evidence suggests that bilirubin is a potent antioxidant and cytoprotective agent against MetS. Ho... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 11, 2024 Category: Cardiology Authors: Ae Hee Kim, Da-Hye Son, Mid-Eum Moon, Soyoung Jeon, Hye Sun Lee and Yong-Jae Lee Tags: Research Source Type: research
The relative and combined ability of stress hyperglycemia ratio and N-terminal pro-B-type natriuretic peptide to predict all-cause mortality in diabetic patients with multivessel coronary artery disease
Stress hyperglycemia ratio (SHR) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are independently associated with increased mortality risk in diabetic patients with coronary artery disease (CAD). Ho... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 11, 2024 Category: Cardiology Authors: Le Wang, Chen Wang, Jia-chun Lang, Rong-di Xu, Hong ‑liang Cong, Jing‑xia Zhang, Yue‑cheng Hu, Ting-ting Li, Chun-wei Liu, Hua Yang and Wen‑yu Li Tags: Research Source Type: research
Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonance
Originally designed as anti-hyperglycemic drugs, Glucagon-Like Peptide-1 receptor agonists (GLP-1Ra) and Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated protective cardiovascular effects, ... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 11, 2024 Category: Cardiology Authors: Angelica Cersosimo, Nadia Salerno, Jolanda Sabatino, Alessandra Scatteia, Giandomenico Bisaccia, Salvatore De Rosa, Santo Dellegrottaglie, Chiara Bucciarelli-Ducci, Daniele Torella and Isabella Leo Tags: Review Source Type: research
The worsening effect of paroxysmal atrial fibrillation on left ventricular function and deformation in type 2 diabetes mellitus patients: a 3.0 T cardiovascular magnetic resonance feature tracking study
Atrial fibrillation (AF) has been linked to an increased risk of cardiovascular death, overall mortality and heart failure in patients with type 2 diabetes mellitus (T2DM). The present study investigated the a... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 6, 2024 Category: Cardiology Authors: Xue-Ming Li, Wei-Feng Yan, Ke Shi, Rui Shi, Li Jiang, Yue Gao, Chen-Yan Min, Xiao-Jing Liu, Ying-Kun Guo and Zhi-Gang Yang Tags: Research Source Type: research
Use of the energy waveform electrocardiogram to detect subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
Recent guidelines propose N-terminal pro-B-type natriuretic peptide (NT-proBNP) for recognition of asymptomatic left ventricular (LV) dysfunction (Stage B Heart Failure, SBHF) in type 2 diabetes mellitus (T2DM... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 6, 2024 Category: Cardiology Authors: Cheng Hwee Soh, Alex G. C. de S á, Elizabeth Potter, Amera Halabi, David B. Ascher and Thomas H. Marwick Tags: Research Source Type: research
Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis
Platelets play an important role in the development of cardiovascular disease (CVD). Mean platelet volume (MPV) is considered as biological marker of platelets activity and function. The aim of the present stu... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 2, 2024 Category: Cardiology Authors: Velia Cassano, Giuseppe Armentaro, Domenico Iembo, Sofia Miceli, Teresa V. Fiorentino, Elena Succurro, Maria Perticone, Franco Arturi, Marta L. Hribal, Tiziana Montalcini, Francesco Andreozzi, Giorgio Sesti, Arturo Pujia and Angela Sciacqua Tags: Research Source Type: research
The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice
Type-2 diabetes (T2D) worsens stroke recovery, amplifying post-stroke disabilities. Currently, there are no therapies targeting this important clinical problem. Sodium-glucose cotransporter 2 inhibitors (SGLT2... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 29, 2024 Category: Cardiology Authors: Ellen Vercalsteren, Dimitra Karampatsi, Carolina Buizza, Thomas Nystr öm, Thomas Klein, Gesine Paul, Cesare Patrone and Vladimer Darsalia Tags: Research Source Type: research
The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005 –2018
The Stress hyperglycemia ratio (SHR) is a novel marker reflecting the true acute hyperglycemia status and is associated with clinical adverse events. The relationship between SHR and mortality in patients with... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 28, 2024 Category: Cardiology Authors: Lei Ding, Hongda Zhang, Cong Dai, Aikai Zhang, Fengyuan Yu, Lijie Mi, Yingjie Qi and Min Tang Tags: Research Source Type: research
